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Abstract 
Background  Cardiac arrhythmias are common conditions in older people. Unfortunately, there is limited literature on associations 
between cardiac arrhythmias and physical performance or disability. We therefore aimed to prospectively investigate associations between 
cardiac arrhythmias and changes in disability and physical performance during 8 years of follow-up, using data from the Italian Longitudinal 
Study on Aging (ILSA). Methods  Cardiac arrhythmias diagnosis was posed through a screening phase, confirmed by a physician. The 
onset of disability in activities of daily living (ADL) and the changes in several physical performance tests during follow-up were considered 
as outcomes. Fully-adjusted and propensity-score Cox Proportional Hazard models and mixed models were used for exploring associations 
between cardiac arrhythmia and the outcomes of interest. Results  The prevalence of cardiac arrhythmia at baseline was 23.3%. People 
reporting cardiac arrhythmia at the baseline were significantly older, more frequently male, smokers and reported a higher presence of all 
medical conditions investigated (hypertension, heart failure, angina, myocardial infarction, diabetes, stroke), but no difference in dementia, 
Parkinsonism, cognitive or mood disorder. Cardiac arrhythmia at baseline was significantly associated with the incidence of disability in 
ADL (HR = 1.23; 95%: CI: 1.01–1.50; P = 0.0478 in propensity score analyses; HR = 1.28; 95% CI: 1.01–1.61; P = 0.0401 in fully adjusted 
models). Cardiac arrhythmia at baseline was also associated with a significant worsening in balance test (P = 0.0436). Conclusions  The pres-
ence of cardiac arrhythmia at baseline was associated with a significant higher risk of disability and of worsening in some physical per-
formance tests, particularly those relating to balance. Screening and frequently assessing physical performance in older people affected by 
cardiac arrhythmia can be important to prevent a loss of physical performance, with further, potential, complications of medical management. 
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1  Introduction 
Cardiac arrhythmia are common conditions in older peo-
ple, and atrial fibrillation (AF) is the most frequent. The 
estimated number of individuals with cardiac arrhythmia in 
the world in 2010 was 33.5 million.[1] It is well known that 
these cardiac conditions are associated with several negative 
outcomes in older people, including stroke,[2] heart failure,[3] 
and mortality.[4] 
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Cardiac arrhythmias, in particular AF, represent a sig-
nificant public health problem, and novel estimates suggest 
that this condition accounts for 1% of the National Health 
Service budget in the United Kingdom[5] and $16 to 26 bil-
lion of annual US expenses.[6] 
Even if of epidemiological importance, there is limited 
literature regarding the impact of cardiac arrhythmias on 
disability and physical performance in older people. In a 
large epidemiological Italian study, AF was significantly 
and strongly associated with physical disability, but these 
findings were cross-sectional.[7] In the Health, Aging, and 
Body Composition Study, participants with AF had a sig-
nificantly greater 4-year upper and lower limbs decline than  
those without AF.[8] However, this longitudinal study is one 
of the few investigating this topic. To the best of our 
knowledge, in fact, there is no clearly defined association 
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between cardiac arrhythmias and functional capacity and the 
adjustment for potential confounders (such as age, sex, race, 
socioeconomic level, other cardiac diseases, and medication 
use) is often not considered.[9] 
Given this background, we aimed to prospectively inves-
tigate associations between cardiac arrhythmias and changes 
in disability and physical performance during eight years of 
follow-up in a large Italian cohort of older people. 
2  Methods 
2.1  Participants 
This study is based on the Italian Longitudinal Study on 
Aging (ILSA), a prospective, community-based cohort study.[10] 
An initial sample of 5632 individuals aged 65 to 84 years, 
stratified by age and sex using an equal allocation strategy, 
was identified on the demographic lists of the registry of-
fices of eight municipalities (urban, suburban, rural). 
The ILSA study was conducted according to the guide-
lines laid down in the Declaration of Helsinki and all pro-
cedures involving human subjects were approved by the 
Ethics Committees of the participating centers. 
The ILSA cohort was firstly examined in 1992 (baseline 
assessment) and re-examined in two waves in 1996 and 2000. 
2.2  Baseline assessments  
The baseline evaluation had screening and clinical con-
firmation phases of several chronic conditions. In particular, 
the screening phase (all participants participated in this 
phase) included a fasting blood sample; a personal interview 
during which the participants were asked about health prob-
lems and specific risk factors; a physician’s examination 
including tests such as the Mini Mental State Examination 
(MMSE),[11] the Geriatric Depression Scale (GDS),[12] the 
Activities of Daily Living (ADL),[13] spirometry, electrocar-
diography, the examination of heart, lungs, pulses and bruits 
and a neurological examination. Anthropometric measures 
were also evaluated and data on medications used were col-
lected. 
The clinical confirmation phase was administered by 
specialists only to participants who screened positive for 
medical chronic conditions, through a standardized clinical 
examination. The criteria for diagnoses and the method to 
calculate prevalence rates have been published elsewhere.[14] 
2.3  Disability in ADL 
Each ADL item was originally scored between 1 and 3, 
with 1 indicating complete independence and 3 indicating 
total dependence. An adjusted total score, varying between 
0.33 and 1, was obtained dividing the total score of the an-
swered items by the sum of scores of these items in the as-
sumption of complete dependency. A score of 0.33 means 
that the subject was completely independent (no disability), 
a score between 0.33 and 0.56 revealed a dependency in a 
maximum of two ADLs (mild disability), a score between 
0.56 and 0.78 a dependency in a maximum of three ADLs 
(moderate disability), and a score between 0.78 and 1 de-
pendency in four or more ADLs (severe disability). 
2.4  Exposure: cardiac arrhythmia diagnosis 
The presence of cardiac arrhythmia was diagnosed in two 
steps: phase 1 (screening). (a): positive questionnaire (self- 
reported diagnosis and medical treatment or pacemaker) or 
(b). diagnostic electrocardiography (computerized diagno-
sis). The screening phase was further confirmed by a phase 
2 (medical confirmation). A physician reviewed clinical re-
cords (electrocardiography, 24-h Holter monitoring) and the 
diagnosis of cardiac arrhythmia was confirmed by the par-
ticipant’s physician and by the clinical evaluation of the 
ILSA internists.[14] Details related to the diagnosis of cardiac 
arrhythmia are available in supplemental Table S1. 
2.5  Outcomes: incident disability and changes in physical 
performance during follow-up 
Several outcomes of our interest were included. First, the 
onset of disability in ADL during follow-up;[13] second, the 
changes in physical performance tests, such as chair stands 
time[15] and gait speed (over 5 m).[16] 
2.6  Statistical analysis  
To generalize the ILSA sample to the Italian population, 
a set of weights defined according to the sex, the age distri-
bution of the reference population (Census 1991, available 
at demo.istat.it) and the sample fraction, was applied to the 
analyses. 
The association of baseline characteristics and the pres-
ence of arrhythmia at baseline was evaluated using the χ2 or 
exact test for categorical variables, or generalized linear 
model, testing for homoschedasticity through Levene’s test 
for quantitative variables. 
Propensity scores were estimated by logistic regression 
models including cardiac arrhythmia as dependent variable 
and unbalanced features (exceeding 10% of difference at 
univariate analysis) as independent variables. 
Incidence of disability in ADL, defined as the transition 
from no disability at baseline to mild, moderate or severe 
disability during follow-up, was evaluated through Cox 
proportional hazard models, with death as competing risk, 
adjusting (a) only for age and sex, (b) for other covariates 
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associated with the outcomes with P < 0.10 at the univariate 
analysis and for incidence of stroke between baseline and 
follow-ups, (c) with propensity-score as covariate. The pro-
portional hazard assumption was verified considering Scho-
enfeld’s residuals of the covariates, and interactions be-
tween variables were evaluated. Incidence of disability in 
physical performance tests defined as the transition from 
baseline to follow-ups from < 2 s (without hand) to ≥ 2 s 
(with or without hands) for chair stands, and as a transition 
from ≥ 0.8 m/s to < 0.8 m/s for gait speed, were evaluated 
following the same procedure. 
Mixed models were finally defined to estimate the dif-
ferences in physical performance tests results according to 
the presence of cardiac arrhythmia, adjusting for baseline 
score, age, sex and propensity-score. 
All analyses were two-sided, and P < 0.05 was consid-
ered significant. The analyses were performed using SAS 
statistical package, release 9.4 (SAS, Cary, NC). 
3  Results 
Among 5,632 older people initially included in the ILSA 
study, 4,277 were included in this research. The mean age 
was 72.4 ± 5.6 years and participants were predominantly 
female (58.5%). The main characteristics of the population 
included during follow-up are reported in Table S2. 
Table 1 shows the baseline characteristics of the included 
population, by the presence or not of cardiac arrhythmia. 
People reporting cardiac arrhythmia at the baseline (n = 996, 
23.3%) were significantly older, more frequently male, 
smokers, wine drinkers, and had lower mean BMI levels 
than those without arrhythmia (n = 3,282) (Table 1). People 
with cardiac arrhythmia reported significantly higher values 
of creatinine, but significantly lower values for serum cho-
lesterol and fibrinogen. As reported in Table 1, people with 
cardiac arrhythmia reported a significant higher presence of 
all medical conditions investigated (hypertension, heart 
failure, angina, myocardial infarction, diabetes, stroke), but 
no difference in dementia, Parkinsonism, cognitive or mood 
disorder. Participants with cardiac arrhythmia reported a 
higher median number of medications used and a higher 
prevalence of antithrombotic agents use. 
People reporting cardiac arrhythmia did not report any 
difference in ADL disability (P = 0.4396) at baseline. Peo-
ple with arrhythmia scored significantly worse in chair 
stands time (P = 0.0351), but not in 5-m gait speed (P = 
0.1907) (Table 1). 
Table 2 shows the association between presence of car-
diac arrhythmia at baseline and the outcomes of our interest 
during eight years of follow-up. Cardiac arrhythmia at base-
line was significantly associated with the incidence of dis-
ability in ADL (HR = 1.23; 95% CI: 1.01–1.50; P = 0.0478 
in propensity score analyses; HR = 1.28; 95% CI: 1.01–1.61; 
P = 0.0401 in fully adjusted models), whilst no significant 
association was observed for incident impairment in gait 
speed or in chair stands time (Table 2).  
Supplemental Figure S1 and Table S3 report the associa-
tion between arrhythmia at baseline and changes in physical 
performance tests during follow-up time according to mixed 
models. Arrhythmia at baseline was associated with a sig-
nificant worsening in one leg stand (P = 0.0436) and with a 
borderline significant worsening in number of steps neces-
sary for a rotation of 180° (P = 0.0547). 
4  Discussion 
In this paper, with a mean follow-up period of 8 years, it 
was shown that the presence of cardiac arrhythmia at base-
line was significantly associated with the onset of disability 
and to a worsening in some physical tests, particularly those 
that regard balance. To the best of our knowledge, this is 
one of the few cohort studies reporting these potential asso-
ciations. 
Prior works investigating cardiac arrhythmias (in par-
ticular AF) and physical frailty (a stage often preceding 
disability) in older adults are still limited. A cross-sectional 
study of older adults living in the community reported a sig-
nificant association between AF and impaired gait speed,[17] 
but did not assess the prospective association of AF to gait 
speed impairment. Studies among hospitalized older people 
have reported increased frailty risk in older adults with AF, 
but relied on self-reported disability and did not use a vali-
dated definition of frailty.[18,19] Finally, in one cohort study 
among American older people living in the community, the 
authors found that the presence of AF was associated with 
an increased risk of decline in some physical performance 
tests, such as the short physical performance battery.[8] 
However, they did not explore the potential association be-
tween cardiac arrhythmias and the onset of disability as in 
the current study. 
It can be hypothesized that associations between cardiac 
arrhythmias and decline in physical performance and dis-
ability are strongly interrelated. It is widely known that car-
diac arrhythmias can have both cardiovascular and non-car-
diovascular clinical manifestations and that, for example, 
cardiovascular diseases are strongly associated with the 
development of frailty.[20,21] Moreover, some risk factors 
(such as obesity and diabetes) are common between cardiac 
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Table 1.  Baseline characteristics of participants considered in the analysis (weighted data). 
Arrhythmia 
 
Overall 
(n = 4277) No (n = 3282) Yes (n = 996) P-value 
General characteristics     
Age, yrs 72.4 ± 5.6 72.0 ± 5.6 73.2 ± 5.4 < 0.0001 
Sex, females 2503 (58.5%) 1980 (60.3%) 523 (52.5%) < 0.0001 
Marital status, married or cohabiting 2491 (58.3%) 1910 (58.3%) 581 (58.4%) 0.9496 
Education, elementary school or less 3011 (71.4%) 2329 (77.3%) 682 (69.2%) 0.0825 
Smoking status, current/former smoker 1813 (42.7%) 1348 (41.5%) 465 (46.8%) < 0.0001 
Wine drinker 3182 (75.0%) 2413 (74.2%) 769 (77.8%) 0.0200 
BMI, kg/m2 27.1 ± 4.6 27.3 ± 4.7 26.8 ± 4.2 0.0032 
Abdominal circumference, cm 97.4 ± 12.2 97.5 ± 12.7 97.1 ± 10.8 0.2541 
Bio-humoral parameters     
Creatinine, mg/dL 1.02 ± 1.53 1.01 ± 1.79 1.03 ± 0.42 < 0.0001 
Cholesterol, mg/dL 222.0 ± 43.7 223.5 ± 43.9 217.9 ± 42.9 0.0002 
Triglycerides, mg/dL 150.9 ± 82.1 151.1 ± 85.1 150.4 ± 74.0 0.7270 
HDL, mg/dL 49.6 ± 13.7 49.7 ± 14.4 49.2 ± 11.4 0.6704 
Fibrinogen, mg/dL 357.6 ± 98.4 359.5 ± 100.9 352.3 ± 91.8 0.0461 
Glycaemia, mg/dL 105.9 ± 35.2 106.0 ± 37.3 105.6 ± 29.5 0.7173 
Medical conditions     
Hypertension 2684 (63.2%) 1992 (61.3%) 691 (69.5%) < 0.0001 
Heart failure 296 (6.9%) 141 (4.3%) 154 (15.5%) < 0.0001 
Angina 326 (7.6%) 186 (5.7%) 140 (14.1%) < 0.0001 
Myocardial Infarction 331 (7.8%) 193 (5.9%) 138 (13.9%) < 0.0001 
Diabetes 581 (13.7%) 419 (12.9%) 162 (16.4%) 0.0052 
Stroke 290 (6.9%) 202 (6.2%) 88 (9.0%) 0.0023 
Dementia 208 (6.3%) 156 (6.4%) 52 (6.0%) 0.6751 
Parkinsonism 123 (2.9%) 94 (2.9%) 29 (3.0%) 0.9358 
MMSE (range 030) 26.8 ± 3.1 26.8 ± 3.1 26.7 ± 3.1 0.4793 
GDS (range 030) 9.3 ± 6.3 9.1 ± 6.4 9.5 ± 6.2 0.4088 
*Medications used, antithrombotic agents 553 (13.4%) 340 (10.7%) 212 (22.2%) < 0.0001 
Total number of medications used, median (Q1, Q3) 1 (1, 2) 1 (1, 2) 2 (1, 2) < 0.0001 
Disability items     
ADL    0.4396 
No disability 2198 (67.3%) 1634 (67.8%) 567 (65.9%)  
Mild disability 863 (26.4%) 620 (25.8%) 242 (28.1%)  
Moderate disability 129 (4.0%) 94 (3.9%) 35 (4.1%)  
Severe disability 76 (2.3%) 60 (2.5%) 16 (1.9%)  
Physical performance tests     
Chair stands test    0.0351 
Not possible 265 (8.1%) 204 (8.5%) 61 (7.1%)  
With hands, ≥ 2 s 112 (3.4%) 70 (2.9%) 42 (4.9%)  
With hands, < 2 s 163 (5.0%) 120 (5.0%) 43 (5.0%)  
Without hands, ≥ 2 s 117 (3.6%) 81 (3.4%) 36 (4.2%)  
Without hands, < 2 s 2608 (79.9%) 1931 (80.3%) 678 (78.7%)  
Gait speed (5-m) test    0.1907 
Not possible 392 (12.0%) 300 (12.5%) 92 (10.7%)  
< 0.8 m/s 1402 (43.0%) 1086 (45.3%) 377 (43.8%)  
≥ 0.8 m/s 1462 (44.9%) 1010 (42.2%) 391 (45.5%)  
Data are presented as mean ± SD or n (%). ADL: activities of daily living; BMI: body mass index; GDS: geriatric depression scale; MMSE: mini-mental state 
examination. *Anatomic Therapeutic Classification code B01 (antithrombotic agents). 
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Table 2.  Multivariable models. 
 Model (a) Model (b) Model (c) 
 HR 95% CI P-value HR 95% CI P-value HR 95% CI P-value 
*Incidence of disability in ADL 
Arrhythmia 1.17 0.981.41 0.0818 1.28 1.011.61 0.0401 1.23 1.011.50 0.0478 
          
#From Gait Speed ≥ 0.8 m/s to < 0.8 m/s 
Arrhythmia 1.12 0.911.38 0.2801 1.14 0.891.45 0.3088 1.16 0.921.47 0.2074 
          
†From Chair Stands without hands < 2 s to ≥ 2 s or with hands 
Arrhythmia 1.18 0.941.48 0.1641 1.38 1.041.83 0.0238 1.09 0.841.42 0.4966 
Model (a): adjusted only for age and sex; model (b): adjusted for age, sex and other covariates associated with the outcome with P < 0.10 at univariate analysis 
(marital status, education, smoking status, hypertension, heart failure, myocardial infarction, diabetes, stroke, dementia, Parkinsonism, incident stroke between 
baseline and follow-ups, use of antithrombotic agents, creatinine at the baseline, cholesterol at the baseline); model (c): propensity-score as covariate (estimated 
by logistic regression models including arrhythmia as dependent variable and unbalanced features as independent variables). *Incidence of disability in ADL: 
from none disability in ADL at baseline to disability in at least one ADL at follow-ups (1995–1997 or 2000-2001). Results from a Cox proportional Hazard 
model (death as competing risk) among participants with no disability in ADL at baseline (n = 670 had mild, moderate or severe disability at follow-ups; n = 
210 died at follow-ups; n = 1167 had no disability at follow-ups). #From Gait Speed ≥ 0.6 m/s to < 0.6 m/s: results from a Cox proportional Hazard model 
(death as competing risk) among participants with Gait Speed ≥ 0.6 m/s at baseline (n = 247 had a Gait Speed < 0.6 m/s at follow-ups; n = 247 died at fol-
low-ups; n = 929 had a Gait Speed ≥ 0.6 m/s at follow-ups). †From Chair Stands without hands < 2 s to ≥ 2 s or with hands: results from a Cox proportional 
Hazard model (death as competing risk) among participants with Chair Stands without hands < 2 s at baseline (n = 372 had a Chair Stands ≥ 2 s or with hands 
at follow-ups; n = 288 died at follow-ups; n = 1153 had a Chair Stands without hands < 2 s at follow-ups). ADL: activities of daily living. 
 
arrhythmias and the worsening of physical performance and 
disability.[22,23] Other sub-clinical cardiovascular disease (e.g., 
coronary calcifications) and inflammation may also be asso-
ciated with cardiac arrhythmias and declining physical per-
formance/disability.[24] Silent cerebral infarcts often secondary 
to cardiac arrhythmias were not available in the ILSA study, 
but may also affect physical performance in older adults.[25] 
Moreover, cardiac arrhythmias might contribute directly 
towards the decline in physical performance and the onset 
of disability. All cardiac arrhythmias, in fact, may alter atrial 
structure and performance, modify atrial refractoriness, re-
duce atrial transport (in systolic phase), and probably pro-
mote the onset of atrial fibrosis.[26] Moreover, irregular heart 
rates diminish left ventricular filling and cardiac output, 
with a consequent less vascularization of the muscles.[27] 
These structural and electrical cardiac changes may ulti-
mately impair peripheral perfusion and diminish capacity 
for activities of daily living.[28] 
Finally, we would like to observe that our study suggests 
that the presence of cardiac arrhythmias is significantly as-
sociated with an impaired balance during the follow-up pe-
riod. In our opinion, this finding is of great clinical impor-
tance since people with cardiac arrhythmias usually take 
oral anticoagulants and the risk of falls in these subjects is 
likely increased by the presence of cardiac arrhythmia itself, 
further strengthening the necessity of a strict medical moni-
toring (also in terms of falls) in these people.  
The findings of our study should be interpreted within 
light of its limitations. First, the definition of cardiac ar-
rhythmias did not differentiate between AF and the other 
common forms observed in the elderly. This fact could be 
relevant because cardiac arrhythmias can have significantly 
different clinical weights, with AF representing a major 
determinant of quality of life and a relevant source of mor-
bidity and mortality among older patients.[29,30] Second, a 
consistent part of people originally included in the ILSA 
study were lost during follow-up evaluations, but this find-
ing is common in cohort studies including older people. 
In conclusion, our study suggests that, in older commu-
nity-dwelling individuals, the presence of cardiac arrhyth-
mias predicts disability development, particularly in balance 
function. Since cardiac arrhythmias are common in the eld-
erly, the screening and the monitoring of patients with rhy-
thm disturbances is needed to prevent a loss of physical per-
formance, with further, potential, complications of medical 
management. 
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Figure S1a.  Changes in “chair stand time” test during fol-
low-up (time 0: baseline; time 1: first follow-up; time 2: the second 
follow-up) 
 
Figure S1b.  Changes in “climbing one step” test during fol-
low-up (time 0: baseline; time 1: first follow-up; time 2: the second 
follow-up). 
 
Figure S1c.  Changes in “tandem walk” test during follow-up 
(time 0: baseline; time 1: first follow-up; time 2: the second fol-
low-up). 
 
Figure S1d.  Changes in “one-leg stand” test during follow-up 
(time 0: baseline; time 1: first follow-up; time 2: the second fol-
low-up). 
 Figure S1e.  Changes in “5-m walk” test during follow-up 
(time 0: baseline; time 1: first follow-up; time 2: the second fol-
low-up). 
 
Figure S1f.  Changes in “number of steps needed to turn 
around” during follow-up (time 0: baseline; time 1: first fol-
low-up; time 2: the second follow-up). 
Table S1.  Criteria used for cardiac arrhythmia diagnosis in the ILSA Study 
During the Phase 1 (screening) of the study, participants were asked to fill out a questionnaire and they underwent an electrocardiogram (ECG).  
A diagnosis of arrhythmia was suspected when: 
 an individual responded affirmatively to the question: “Has a physician ever mentioned that you have arrhythmia, that is, an irregular heart beat?” 
 OR an individual responded affirmatively to the question: “Do you have a pacemaker (a device that generates electrical impulses to help the heart beat 
regularly)?” 
 OR an individual presented an ECG tracing showing arrhythmia and conduction disorders. 
Participants with the following characteristics entered Phase 2 (medical confirmation): 
 a positive questionnaire; 
 an ECG positive for arrhythmia; 
 both of the above. 
During Phase 2, a physician reviewed clinical records (ECG, 24-h Holter monitoring) and the diagnosis of cardiac arrhythmia was confirmed by the par-
ticipant’s physician and by the clinical evaluation of the ILSA internists.  
For the individuals entering Phase 2 of the study considering only a positive questionnaire, the specialist sought diagnostic confirmation by requesting a 
complete hospital report if the patient had ever been hospitalized. When that was not the case, the individual’s general practitioner was asked to fill out the 
questionnaire for coronary artery pathology. 
 
Table S2.  ILSA study participants across examination years (weighted data; only participants with information on arrhythmia) 
 Baseline 1st follow-up 2nd follow-up 
Years 1992-93 1995-97 2000-01 
Age (years), mean ± SD 72.4±5.6 74.9±5.6 78.9±5.3 
Number of participants 4277 2936 2009 
Participants with arrhythmia self-reported, n (%) 855 (20.9) 605 (21.6) 397 (20.2) 
Participants with arrhythmia diagnosed, n (%) 996 (23.3) -- -- 
PPT available, n (%) 3189 (74.6) 1897 (64.6) 1461 
ADL available, n (%) 3266 (76.4) 2924 (99.0) 1964 (97.7) 
*SD: standard deviation; AF: atrial fibrillation; PPT: Physical Performance Test; ADL: Activities of Daily Living 
 
 
Table S3.  Decline in chair stand time and gait speed, by arrhythmia (diagnosed by clinicians) 
 
Participants without arrhy- 
thmia at baseline mean (SE) 
Participants with arrhythmia 
at baseline mean (SE) 
Difference between-group, 
mean (SE) 
p-value§
Chair stand, seconds 
Baseline 
1st Follow-up 
2nd Follow-up 
 
1.07 (0.02) 
0.83 (0.02) 
1.58 (0.03) 
 
1.06 (0.03) 
0.83 (0.04) 
1.69 (0.05) 
 
0.01 (0.04) 
0.01 (0.05) 
0.11 (0.06) 
0.1997*
0.6981 
0.9534 
0.0707 
Climbing one step, n. of proofs 
Baseline 
1st Follow-up 
2nd Follow-up 
 
3.59 (0.03) 
3.56 (0.03) 
3.07 (0.05) 
 
3.62 (0.04) 
3.52 (0.06) 
3.03 (0.08) 
 
0.03 (0.05) 
0.03 (0.07) 
0.04 (0.09) 
0.6351*
0.5417 
0.5951 
0.6568 
Tandem walk, n. of mistakes 
Baseline 
1st Follow-up 
2nd Follow-up 
 
2.53(0.06) 
3.49 (0.08) 
5.66 (0.11) 
 
2.47 (0.10) 
3.42 (0.13) 
5.09 (0.18) 
 
0.07 (0.12) 
0.07 (0.16) 
0.58 (0.21) 
0.0846*
0.5547 
0.6561 
0.0056 
One-leg stand, seconds 
Baseline 
1st Follow-up 
2nd Follow-up 
 
12.3 (0.18) 
9.4 (0.23) 
6.8 (0.31) 
 
12.3 (0.30) 
10.5 (0.38) 
6.1 (0.53) 
 
0.10 (0.35) 
1.08 (0.45) 
0.72 (0.61) 
0.0436*
0.7851 
0.0169 
0.2357 
Gait speed, m/sec 
Baseline 
1st Follow-up 
2nd Follow-up 
 
0.99 (0.06) 
0.81 (0.07) 
0.78 (0.09) 
 
0.92 (0.10) 
1.02 (0.12) 
0.82 (0.15) 
 
0.08 (0.11) 
0.21 (0.14) 
0.04 (0.18) 
0.3407*
0.4858 
0.1422 
0.8191 
Number of steps needed to turn around 
Baseline 
1st Follow-up 
2nd Follow-up 
 
3.10 (0.03) 
3.45 (0.03) 
3.95 (0.04) 
 
3.02 (0.04) 
3.49 (0.06) 
4.09 (0.07) 
 
0.09 (0.05) 
0.03 (0.07) 
0.14 (0.09) 
0.0547*
0.0932 
0.6005 
0.1081 
§: p-value from mixed-model repeated measures analyses, adjusted for baseline score 
* p-value for group*time interaction 
